Identification

Author

Craigle V

Title

MedWatch: The FDA safety information and adverse event reporting program

Year

2007

Publication type

Article

Journal

J Med Libr Assoc

Created

2012-10-11 14:42:35+00:00

Modified

2016-07-27 16:32:27.259072+00:00

Details

Volume

95

Number

2

Access

Language

English

URL http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852611/
DOI

10.3163/1536-5050.95.2.224

Accessed

2016-07-13

Extended information

Abstract

An alarming report issued recently by the Institute of Medicine (IOM) found that adverse drug events injure an estimated 1.5 million people each year, at a cost of approximately $3.5 billion dollars [1]. If these statistics seem inordinately high, consider that the numbers do not factor in lost wages, productivity, or additional health care costs incurred as a result of these injuries.

The National Academies, deeply concerned about the health implications of IOM's findings, urged government agencies, health care professions, and communities to work together to improve patient– provider partnerships, create new and improved drug information resources, and simplify complicated drug naming and labeling.